Group One Trading’s Adverum Biotechnologies ADVM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-900
| Closed | -$4.08K | – | 8008 |
|
|
2025
Q3 | $4.08K | Sell |
900
-1,000
| -53% | -$2.95K | ﹤0.01% | 7641 |
|
|
2025
Q2 | $4.08K | Buy |
1,900
+900
| +90% | +$2.52K | ﹤0.01% | 7170 |
|
|
2025
Q1 | $4.37K | Buy |
1,000
+900
| +900% | +$4.06K | ﹤0.01% | 6710 |
|
|
2024
Q4 | $467 | Sell |
100
-4,900
| -98% | -$33K | ﹤0.01% | 7008 |
|
|
2024
Q3 | $35.1K | Buy |
+5,000
| New | +$36.3K | ﹤0.01% | 4892 |
|
|
2024
Q2 | – | Sell |
-205,900
| Closed | -$2.91M | – | 6632 |
|
|
2024
Q1 | $2.91M | Buy |
+205,900
| New | +$3.13M | 0.01% | 1214 |
|
|
2022
Q2 | – | Sell |
-6,640
| Closed | -$87K | – | 7716 |
|
|
2022
Q1 | $87K | Sell |
6,640
-90
| -1% | -$1.32K | ﹤0.01% | 5625 |
|
|
2021
Q4 | $118K | Buy |
6,730
+6,380
| +1,823% | +$128K | ﹤0.01% | 5575 |
|
|
2021
Q3 | $8K | Sell |
350
-70
| -17% | -$1.79K | ﹤0.01% | 7583 |
|
|
2021
Q2 | $15K | Sell |
420
-2,020
| -83% | -$109K | ﹤0.01% | 7333 |
|
|
2021
Q1 | $241K | Sell |
2,440
-550
| -18% | -$66K | ﹤0.01% | 4831 |
|
|
2020
Q4 | $324K | Buy |
2,990
+2,670
| +834% | +$330K | ﹤0.01% | 3666 |
|
|
2020
Q3 | $33K | Sell |
320
-520
| -62% | -$77.9K | ﹤0.01% | 4879 |
|
|
2020
Q2 | $175K | Hold |
840
| – | – | ﹤0.01% | 3495 |
|
|
2020
Q1 | $82K | Buy |
840
+560
| +200% | +$65.3K | ﹤0.01% | 3429 |
|
|
2019
Q4 | $32K | Sell |
280
-7,590
| -96% | -$669K | ﹤0.01% | 4194 |
|
|
2019
Q3 | $429K | Buy |
7,870
+4,370
| +125% | +$493K | ﹤0.01% | 2462 |
|
|
2019
Q2 | $416K | Buy |
3,500
+3,480
| +17,400% | +$288K | ﹤0.01% | 2301 |
|
|
2019
Q1 | $1K | Sell |
20
-200
| -91% | -$8.09K | ﹤0.01% | 4641 |
|
|
2018
Q4 | $7K | Buy |
+220
| New | +$8.95K | ﹤0.01% | 4375 |
|
|
2018
Q2 | – | Sell |
-3,610
| Closed | -$209K | – | 5034 |
|
|
2018
Q1 | $209K | Buy |
3,610
+1,100
| +44% | +$68.5K | ﹤0.01% | 2767 |
|
|
2017
Q4 | $88K | Buy |
2,510
+1,990
| +383% | +$65.5K | ﹤0.01% | 3419 |
|
|
2017
Q3 | $19K | Hold |
520
| – | – | ﹤0.01% | 4081 |
|
|
2017
Q2 | $13K | Sell |
520
-500
| -49% | -$13.7K | ﹤0.01% | 4102 |
|
|
2017
Q1 | $28K | Sell |
1,020
-500
| -33% | -$14.2K | ﹤0.01% | 3722 |
|
|
2016
Q4 | $44K | Buy |
1,520
+1,270
| +508% | +$41.5K | ﹤0.01% | 3322 |
|
|
2016
Q3 | $10K | Sell |
250
-520
| -68% | -$19.7K | ﹤0.01% | 4041 |
|
|
2016
Q2 | $24K | Sell |
770
-580
| -43% | -$26.2K | ﹤0.01% | 3701 |
|
|
2016
Q1 | $70K | Buy |
1,350
+370
| +38% | +$20.7K | ﹤0.01% | 3066 |
|
|
2015
Q4 | $93K | Sell |
980
-18,380
| -95% | -$1.61M | ﹤0.01% | 3012 |
|
|
2015
Q3 | $1.59M | Buy |
19,360
+3,150
| +19% | +$402K | 0.02% | 929 |
|
|
2015
Q2 | $2.63M | Buy |
16,210
+14,250
| +727% | +$4.81M | 0.04% | 589 |
|
|
2015
Q1 | $794K | Buy |
+1,960
| New | +$829K | 0.01% | 1259 |
|
Group One Trading's ADVM Position: Q2 2025 in Review
Group One Trading sold out of Adverum Biotechnologies (ADVM) in Q2 2025, closing a stake of 292 shares — an estimated $817 sold.
Group One Trading first reported a position in ADVM in Q1 2015 and held it in 25 quarters. The position peaked at $2.34M in Q2 2015. 58 funds tracked by Wall St. Rank hold ADVM as of Q2 2025.
- Group One Trading reported no remaining Adverum Biotechnologies position as of Q2 2025 after selling out during the quarter.
- Group One Trading sold 292 Adverum Biotechnologies shares in Q2 2025, an estimated $817.
- Group One Trading first reported a position in Adverum Biotechnologies in Q1 2015 and held it in 25 quarters.
- Group One Trading's Adverum Biotechnologies position peaked at $2.34M in Q2 2015.
- 58 funds tracked by Wall St. Rank held Adverum Biotechnologies as of Q2 2025.
Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.